The Influence Of The Hormone Therapy On The Lacrimal Film In Postmenopausal Women
Keywords:
lacrimal film, dry eye syndrome, postmenopause, hormone therapy, ocular symptomsAbstract
Objective
To evaluate whether hormone therapy (HT) administered to postmenopausal women has any effect on "dry eye" symptoms.
Methods
14 postmenopausal patients were evaluated, before and 3 months after the introduction of hormonal therapy. The parameters evaluated were: age, time since menopause, presence of diseases and use of associated medications, ocular signs and symptoms and environmental exposure factors. The ophthalmological examination included corneal topography, Schirmer test, tear film break-up time and complete biomicroscopic examination. The data obtained was subjected to statistical analysis.
Results
The average age of the patients was 53.8 years. The main complaints found were foreign body sensation (35.7%) and tearing (28.5%), both before and after hormone therapy. Corneal topographies showed nonspecific changes, and the Schirmer l and tear film break tests did not show a statistically significant difference before and after the introduction of the medication.
Conclusion
Using the proposed methodology, no influence of hormonal therapy, used for 3 months, on the tear film in postmenopausal women was observed.
Downloads
References
Rebar RW. Os ovários. ln: Wyngaarden JB, Smith Jr LH, Bennett JC. Tratado de medicina interna. 19.ed. Rio de Janeiro: Guanabara Koogan; 1993. p.1402-3.
Mathers WD, Stovall D, Lane JA, Zimmerman MB, Johnson S. Menopause and tear function: the influence of prolactin and sex hormones on human tear production. Cornea 1998; 17(4):353-58.
Liesegang TJ. Tear dysfunction. ln: Wright KW. Textbook of ophthalmology. Baltimore: Williams & Wilkins; 1997. p.655-63.
Murube dei Castillo J. Ojo seco. Granada: Tecnimedia; 1997.
Wenderlein M, Mattes S. The "dry eye" phenomenon and ovarian function. Study of 700 women pre-and postmenopausa. Zentralbl Gynakol 1996; 118(12):643-9.
Schaumberg DA, Buring JE, Sullivan DA, Dana MR. Hormone replacement therapy and dry eye syndrome. JAMA 2001; 286(12):2114-9.
Okon A, Jurowski P, Gos R. The influence of the hormonal replacement therapy on the amount and stability of the tear film among peri and postmenopausal women. Klin Oczna 2001; 103(4-6):177-81.
Vecsei PV, Kircher K, Kaminski S, Nagel G, Breitenecker G, Kohlberger PD. lmmunohistochemical detection of estrogen and progesterone receptor in human cornea. Maturitas 2000; 36(3): 169-72.
Sullivan DA, Krenzer KL, Sullivan BD, Tolls DB, Toda 1, Dana MR. Does androgen insufficiency cause lacrimal gland inflammation and aqueous tear deficiency? lnvest Ophthalmol Vis Sei 1999; 40(6):1261-5.
Esmaeli B, Harvey JT, Hewlett B. lmmunohistochemical evidence for estrogen receptors in meibomian glands. Ophthalmology 2000; 107(1 ): 180-4.
Krenzer KL, Dana MR, Ullman MD, Cermak JM, Tolls KB, Evans JE, et ai. Effect of androgen deficiency on the human meibomian gland and ocular surface. J Clin Endocrinol Metab 2000; 85(12):4874-82.
Worda C, Nepp J, Huber JC, Sator MO. Treatment of keratoconjunctivitis sicca with topical androgen. Maturitas 2001; 37(3):209-12.
Mathers WD. Why the eyes becomes dry: A cornea and lacrimal gland feedback model. CLAO J 2000; 26(3): 159-65.
